# Corning Incorporated – Consensus ‘buy’ rating and 14.2% Upside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-consensus-buy-rating-and-14.2-upside-potential/4121132979
- Published: 2023-11-16T15:16:39+00:00
- Author: Charlotte Edwards

**Corning Incorporated** which can be found using ticker (GLW) now have 10 confirmed
analysts covering the stock with the consensus suggesting a rating of ‘buy’. The
range between the high target price and low target price is between $40.00 and $
28.00 suggesting an average Analsyt target price of $32.50. Given that the stocks
previous close was at $28.46 this now indicates there is a potential upside of 14.2%.
The day 50 moving average is $29.06 while the 200 day moving average is $32.34. 
The market cap for the company is 24.70B. The stock price for the company is currently
$28.95 USD

 The potential market cap would be $28,205,588,149 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 42.57, revenue per share of $15.35
and a 2.92% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on: